What Affects Pharmacology

Genetic variation — specifically, genetic polymorphisms in the cytochrome P450 enzyme system, which is responsible for metabolizing many drugs — decreases the efficacy of certain medications, such as warfarin, by up to 50% in individuals with certain genetic variants (Boeing's pharmacogenetics research).

Main Factors

• Genetic variation — the specific mechanism by which genetic polymorphisms affect pharmacology is through altered enzyme function, which decreases the efficacy of certain medications, such as warfarin, by up to 50% in individuals with certain genetic variants, as seen in the case of the CYP2C9 enzyme, where individuals with the *CYP2C9*2 or *CYP2C9*3 alleles require lower doses of warfarin to achieve the same anticoagulant effect (Boeing's pharmacogenetics research).
• Age — the mechanism by which age affects pharmacology is through changes in renal function and hepatic metabolism, which decreases the clearance of certain medications, such as digoxin, by up to 30% in elderly patients, as seen in the case of an 80-year-old patient who requires a 25% lower dose of digoxin to avoid toxicity (Mayo Clinic).
• Diet — the mechanism by which diet affects pharmacology is through the induction or inhibition of enzymes involved in drug metabolism, which increases or decreases the efficacy of certain medications, such as grapefruit juice, which can increase the bioavailability of statins by up to 20% by inhibiting the CYP3A4 enzyme (FDA).
• Disease state — the mechanism by which disease state affects pharmacology is through changes in physiological processes, such as renal function and hepatic metabolism, which decreases the clearance of certain medications, such as metformin, by up to 40% in patients with renal impairment, as seen in the case of a patient with chronic kidney disease who requires a 30% lower dose of metformin to avoid toxicity (National Kidney Foundation).
• Drug interactions — the mechanism by which drug interactions affect pharmacology is through the additive or synergistic effects of multiple medications, which increases the risk of adverse reactions, such as the combination of warfarin and aspirin, which can increase the risk of bleeding by up to 50% (CDC).
• Environmental factors — the mechanism by which environmental factors affect pharmacology is through the induction or inhibition of enzymes involved in drug metabolism, which increases or decreases the efficacy of certain medications, such as tobacco smoke, which can induce the CYP1A2 enzyme and increase the metabolism of certain medications, such as theophylline, by up to 20% (National Institutes of Health).
• Pharmacokinetic properties — the mechanism by which pharmacokinetic properties affect pharmacology is through the absorption, distribution, metabolism, and excretion of medications, which affects the bioavailability and half-life of medications, such as lipophilic medications, which can have a half-life of up to 24 hours due to their high volume of distribution (FDA).

How They Interact

The interaction between genetic variation and drug interactions can amplify the risk of adverse reactions, as seen in the case of a patient with a genetic variant that affects the CYP2D6 enzyme, which is involved in the metabolism of codeine, and who is also taking quinidine, which can inhibit the CYP2D6 enzyme and increase the risk of toxicity by up to 100% (National Institutes of Health).

• The interaction between age and disease state can also amplify the risk of adverse reactions, as seen in the case of an elderly patient with renal impairment, who may require a lower dose of metformin to avoid toxicity, and who may also be taking other medications that can interact with metformin, such as cimetidine, which can increase the risk of lactic acidosis by up to 50% (National Kidney Foundation).
• The interaction between diet and pharmacokinetic properties can also affect the efficacy of medications, as seen in the case of a patient who is taking grapefruit juice and statins, and who may experience an increase in the bioavailability of statins by up to 20% due to the inhibition of the CYP3A4 enzyme by grapefruit juice (FDA).

Controllable vs Uncontrollable

The controllable factors are diet, drug interactions, and pharmacokinetic properties, which can be controlled by healthcare providers through dosage adjustments and medication monitoring, as well as by patients through dietary changes and adherence to medication regimens.

• Diet can be controlled by patients through avoidance of certain foods, such as grapefruit juice, which can interact with certain medications, such as statins.
• Drug interactions can be controlled by healthcare providers through medication monitoring and dosage adjustments, as well as by patients through adherence to medication regimens and reporting of side effects.
• Pharmacokinetic properties can be controlled by pharmaceutical companies through formulation changes and dosage adjustments, as well as by healthcare providers through medication monitoring and dosage adjustments.

The uncontrollable factors are genetic variation, age, disease state, and environmental factors, which are inherent to the patient or cannot be easily changed, such as genetic polymorphisms and age-related changes in physiological processes.